This article has Open Peer Review reports available.
Sclerosing mesenteritis in a 5-year-old Chinese boy: a case report
© The Author(s). 2017
Received: 26 August 2015
Accepted: 27 July 2017
Published: 1 August 2017
Sclerosing mesenteritis is a rare fibroinflammatory disorder of unknown etiology that primarily affects the mesentery of the small intestine during late adult life. Only about twenty pediatric cases have been reported to date, but none has been reported in Chinese children.
A 5-year-old Chinese male presented with a 4-week history of recurrent bloating, abdominal pain, anorexia and vomiting. On admission, physical examination showed a severely distended abdomen. Biochemical investigations showed a slightly increased C-reactive protein, and normal serum levels of electrolytes and erythrocyte sedimentation rate. An abdominal film showed small intestine obstruction and massive ascites. An exploratory laparotomy revealed widespread inflammatory fibrotic adhesions between the bowel and the abdominal wall, thickening of the small bowel and massive ascites. During a prolonged hospital course, a 2nd surgery (4 months after 1st exploratory laparotomy) was performed in order to close the ileostomy and revealed that the bowel was still severely edematous, with very tight adhesions between the bowel and the abdominal wall. Histopathological examination of excised mesentery and nodules showed chronic inflammatory cell infiltration, fat necrosis and fibrosis. A diagnosis of sclerosing mesenteritis was finally established. Prednisolone at 2 mg/kg was started and he experienced rapid clinical improvement in 4 weeks.
Sclerosing mesenteritis is extremely rare in children and often misdiagnosed due to its nonspecific clinical manifestation. It is important to be aware of sclerosing mesenteritis when evaluating a child with intractable abdominal pain, bloating, intestinal obstruction and massive ascites.
KeywordsSclerosing mesenteritis Intestinal obstruction Child
Sclerosing mesenteritis is a rare non-neoplastic disorder of unknown etiology that primarily affects the mesentery of the small intestine with chronic fibrosing inflammation during late adult life [1–3]. Only about twenty pediatric cases have been reported to date , but none has been reported in Chinese children. It can be an acute or insidious onset and lacks specific clinical manifestations. Abdominal pain and mass are the main symptoms. Here we report the first case of 5-year-old Chinese boy with sclerosing mesenteritis who presented with intractable abdominal pain, bloating, intestinal obstruction and massive ascites.
An exploratory laparotomy was performed. There were widespread dilatation, edema and thickening of the small bowel, with massive clear slightly-yellowish ascites of about 1300 ml. Small intestine mesentery and ascending colon were also thickened, with multiple yellowish nodules. There were extensive intraperitoneal adhesions. No evidence of obstructive pathology was identified. The disease was centered more on the mesentery. With concern for malignancy, nearly 60 cm of bowel including the terminal ileum, ileocecal valve, part of ascending colon and their mesentery, and part of omentum, were resected. An end ileostomy was created.
Post-surgically, the patient was treated with parenteral nutrition, intravenous fluids, gastrointestinal decompression, and pro-motility agents such as mosapride and erythromycin. However, severe bloating persisted and more than 1000 ml of green-yellowish fluids was drained from the decompression tube and 200 ml from the ileostomy daily. With suspicion of eosinophilic enteritis based on pathology report, he was treated with intravenous dexamethasone at 0.2 mg/kg/d, which was gradually decreased to 0.1 mg/kg/day over a 2-week period and stopped after 4 weeks. His abdominal pain decreased and ascites resolved, with a gradual improvement in enteral nutrition intake. While the decompression tube drainage was decreased, the ileostomy drainage increased to more than 1000 ml daily. The second and third barium studies showed some degree of gastrointestinal motility improvement (Fig. 1c and d). Subsequently at 4 months after the initial exploratory laparotomy, a 2nd surgery was performed in order to close the ileostomy and revealed that the bowel was still severely edematous, with very tight adhesions between the bowel and the abdominal wall. Ileostomy closure couldn’t be performed. Tissues near the ileostomy, including bowel and mesentery, were resected and sent for pathological examination, which showed chronic inflammatory cell infiltration, fat necrosis and fibrosis (Fig. 2 d-f). Based on pathological features and clinical presentations, a diagnosis of sclerosing mesenteritis was finally established. Prednisolone at 2 mg/kg was started and he experienced rapid clinical improvement in 4 weeks and was discharged from the hospital. After 8 weeks of treatment, prednisolone was slowly weaned and stopped after 24 weeks. At 8-month after hospital discharge, he was asymptomatic with adequate weight gain. A final surgery (15 months after the initial exploratory laparotomy) was performed to close the ileoostomy and there was no edema but he was noted to have diffusely enterocolonic adhesions. The boy remained asymptomatic at a 6-month post-operation clinic visit.
Sclerosing mesenteritis is a rare chronic fibrosing inflammatory disease of ambiguous pathogenesis primarily diagnosed in late adult life while pediatric cases are very uncommon because children have mesenteric fat than adults [1–3]. It is a benign disorder mainly involving the small-bowel mesentery; however, mesocolon, peripancreatic region, omentum, pelvis or retroperitoneum may be also involved. Both mesenteric panniculitis and mesenteric lipodystrophy are considered to be histological variants of sclerosing mesenteritis . Viswanathan and Murray reported one case and summarized another 16 pediatric cases from the literature and found that the average age at diagnosis in children was 6.5 years . In our case, the lesion was extensive and involved small intestine, ascending mesocolon, omentum and peritoneum, leading to intractable bowel obstruction. Clinical symptoms are usually non-specific, including abdominal pain, anorexia, fatigue, weight loss, fever, abdominal mass, ascites, pericardial effusion, diarrhea and constipation [1–3]. Laboratory examinations including C-reactive protein, erythrocyte sedimentation rate, complete blood count, and biochemistry are also non-specific, which renders a diagnostic challenge for clinicians. Abdominal CT or ultrasonography may play an important role in diagnostic evaluation and the most common finding is a soft tissue mass at the root of small bowel mesentery . In the present case, massive peritoneal cavity effusion resulted in a negative finding on CT scan. A definite diagnosis is dependent on histopathology, which usually reveals fat necrosis, chronic inflammation and fibrosis but can be variable from case to case. These histological variants may reflect the state of a chronic inflammatory process; necrosis in mesenteric fat may represent disease progression and eventually progress to fibrosis which leads to retractile mesenteritis . In the present case, infiltration of chronic inflammatory cells, fat necrosis and fibrosis were all observed in the histological findings from initial and subsequent surgical specimens, but due to lack of awareness of the disease, a diagnosis of sclerosing mesenteritis was not recognized at the first operation. Therefore, due to the nonspecific signs and symptoms of sclerosing mesenteritis, diagnosis is mainly made through a combination of histopathological and imaging (preferably abdominal CT) findings .
A recently defined subtype, IgG4-related sclerosing mesenteritis, has been reported to be closely related to IgG4-related disease and one such case was reported in children [8–10]. In our case, IgG4 serum subclass levels or tissue immunohistochemistry were not performed.
The optimal therapeutic strategy for sclerosing mesenteritis remains unclear. Some asymptomatic or mild clinical cases may resolve spontaneously without therapy. In some cases with intensive fibrosis leading to intractable bowel obstruction or perforation, surgical resection or ileostomy might be required [1–3]. Medications including corticosteroids, thalidomide, cyclophosphamide, colchicine, azathioprine and tamoxifen have been reported to induce remission of sclerosing mesenteritis [11–13]. Most of the previous reported pediatric cases were successfully treated with corticosteroids. Our patient was started on corticosteroids at 2 mg/kg after definitive diagnosis was made and had a clinical remission in 4 weeks. Due to the severity of intestinal inflammation, we decided to keep him on corticosteroids at 2 mg/kg for another 4 weeks and then slowly weaned off it over 6 months.
We describe a very rare case of sclerosing mesenteritis in a Chinese boy. We failed to make a diagnosis at the first operation due to lack of awareness of the disease. Sclerosing mesenteritis should be considered as a differential diagnosis in patients with intractable bowel obstuction and serous cavity effusion. A definite diagnosis is dependent on histopathology. Judicious use of corticosteriods therapy can lead to clinical remission.
The authors acknowledge Dr. Craig Friesen from Children’s Mercy Hospital for critical reading of the manuscript.
No supporting source to declare.
Availability of data and materials
The data supporting the current findings are not publicly available since the database is currently not anonymous and contains all the patients’ names. However, it will be available upon request.
CL contributed to conception and design of the manuscript, clinical management of the patient, and drafted the manuscript. MY, PC, and LG contributed to acquisition, analysis and interpretation of data, and drafting of the manuscript. DL and SG contributed to critical revision of the manuscript for important intellectual content. All authors read and approved the final version of the manuscript.
Ethics approval and consent to participate
This study was approved by the Institutional Ethics Committee of the Guangzhou Women and Children’s Medical Center. Written informed consent was given by the caregiver of the child for his clinical records to be used in this case report.
Consent for publication
Written informed consent was obtained from the patient’s parents for publication of this case report and any accompanying images.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Akram S, Pardi DS, Schaffner JA, Smyrk TC. Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol. 2007;5:589–96.View ArticlePubMedGoogle Scholar
- Viswanathan V, Murray KJ. Idiopathic sclerosing mesenteritis in paediatrics: report of a successfully treated case and a review of literature. Pediatr Rheumatol Online J. 2010;8:5. doi:10.1186/1546-0096-8-5.View ArticlePubMedPubMed CentralGoogle Scholar
- Vlachos K, Archontovasilis F, Falidas E, Mathioulakis S, Konstandoudakis S, Villias C. Sclerosing Mesenteritis: diverse clinical presentations and dissimilar treatment options, a case series and review of the literature. Int Arch Med. 2011;4:17.View ArticlePubMedPubMed CentralGoogle Scholar
- Emory TS, Monihan JM, Carr NJ, Sobin LH. Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity? Am J Surg Pathol. 1997;21:392–8.View ArticlePubMedGoogle Scholar
- Wat SY, Harish S, Winterbottom A, Choudhary AK, Freeman AH. The CT appearances of sclerosing mesenteritis and associated diseases. Clin Radiol. 2006;61:652–8.View ArticlePubMedGoogle Scholar
- Fukuda S, Miyaoka Y, Tsukano K, Ueno S, Izumi D, Yamanouchi S, Yazaki T, Sonoyama T, Ito S, Fujishiro H, Kohge N, Imaoka T. A case of sclerosing mesenteritis diagnosed on the basis of biopsy findings obtained during laparotomy and successfully treated with steroids. Nihon Shokakibyo Gakkai Zasshi. 2014;111:2303–10.PubMedGoogle Scholar
- Sharma P, Yadav S, Needham CM, Feuerstadt P. Sclerosing mesenteritis: a systematic review of 192 cases. Clin J Gastroenterol. 2017;10:103–11.View ArticlePubMedGoogle Scholar
- Chen TS, Montgomery EA. Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders? J Clin Pathol. 2008;61:1093–7.View ArticlePubMedGoogle Scholar
- Avincsal MO, Otani K, Kanzawa M, Fujikura K, Jimbo N, Morinaga Y, Hirose T, Itoh T, Zen Y. Sclerosing mesenteritis: a real manifestation or histological mimic of IgG4-related disease? Pathol Int. 2016; doi:10.1111/pin.12386. [Epub ahead of print]
- Hasosah MY, Satti MB, Yousef YA, Alzahrani DM, Almutairi SA, Alsahafi AF, Sukkar GA, Alzaben AA. IgG4-related sclerosing mesenteritis in a 7-year-old Saudi girl. Saudi J Gastroenterol. 2014;20(6):385–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Bala A, Coderre SP, Johnson DR, Nayak V. Treatment of sclerosing mesenteritis with corticosteroids and azathioprine. Can J Gastroenterol. 2001;15:533–5.View ArticlePubMedGoogle Scholar
- Iwanicki-Caron I, Savoye G, Legros JR, Savoye-Collet C, Herve S, Lerebours E. Successful management of symptoms of steroid- dependent mesenteric panniculitis with colchicine. Dig Dis Sci. 2006;51:1245–9.View ArticlePubMedGoogle Scholar
- Ginsburg PM, Ehrenpreis ED. A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis. Aliment Pharmacol Ther. 2002;16:2115–22.View ArticlePubMedGoogle Scholar